Cel Sci (CVM) Operating Leases (2019 - 2026)
Cel Sci (CVM) recorded Operating Leases of $1.41 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 8.6% from $1.3 million a year earlier but down 3.9% from the prior quarter.
Cel Sci (CVM) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cel Sci reported Operating Leases of $1.26 million, down 11.7% from FY2024.
- Annual Operating Leases has declined for four straight fiscal years, though with a five-year compound annual growth rate of 2.5% (FY2020 to FY2025).
- Across earlier fiscal years, Operating Leases came in at $1.43 million in FY2024 (-13.7%), $1.65 million in FY2023 (-10.7%), $1.85 million in FY2022 (-8.5%) and $2.02 million in FY2021 (+81.4%).
- Quarterly Operating Leases has ranged from $1.26 million in fiscal Q4 2025 to $2.02 million in fiscal Q4 2021 over the past five years.
- On a year-over-year basis, Operating Leases has increased for three consecutive quarters, with an average decline of 4.5% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 96.9% in fiscal Q3 2022, against a decline of 14.1% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.47 million (Q2 2026), $1.52 million (Q1 2026) and $1.26 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 1.76 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.94 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Sep 30, 2021 | 2.02 Mn |
Cel Sci Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CVM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();